This topic contains a solution. Click here to go to the answer

Author Question: Why does a patient who is receiving PAV demand close monitoring of respiratory mechanics throughout ... (Read 38 times)

CharlieWard

  • Hero Member
  • *****
  • Posts: 578
Why does a patient who is receiving PAV demand close monitoring of respiratory mechanics throughout the time that PAV is provided?
 
  A. so that the patient's Vt needs can be attended to
  B. to prevent the occurrence of the runaway effect
  C. to make the necessary volume adjustments ensuring that PAV is effectively provided
  D. to avoid the problems associated with delivering an essentially constant Vt

Question 2

Which of the following problems are associated with using a dual lumen endotracheal tube (DLT) during ILV?
 
  A. Tracheal erosion and necrosis from the low-volume, high-pressure cuff used in conjunction with this tube.
  B. Distal migration of the DLT potentially could block a mainstem bronchus.
  C. The tracheal hook can cause considerable tracheal trauma.
  D. DLTs do not afford access to the affected lung.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alvinum

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

ANS: B

Answer to Question 2

ANS: B




CharlieWard

  • Member
  • Posts: 578
Reply 2 on: Jul 16, 2018
Gracias!


vickybb89

  • Member
  • Posts: 347
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

For a complete list of videos, visit our video library